Eikon Therapeutics Shares Fall in Nasdaq Debut

MT Newswires Live
Feb 06

Eikon Therapeutics (EIKN) shares fell nearly 7% in recent trading on Thursday after its debut on the Nasdaq Stock Exchange.

The stock fell to $16.81 in afternoon trading after the company priced an upsized initial public offering of 21.18 million shares at $18 each.

The initial public offering is slated to close on Friday.

Price: 16.68, Change: -1.32, Percent Change: -7.33

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10